Neurosoft Bioelectronics News - Profile and Newsroom at Send2Press Newswire

Neurosoft Bioelectronics Newsroom - Profile and News Archive

Neurosoft Bioelectronics Ltd. is a Swiss medtech spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL). Neurosoft Bioelectronics develops next generation soft implantable electrodes to interface with the brain for the treatment of severe neurological disorders. Its main product is a fully implantable closed-loop Brain-Computer Interface (BCI) to treat severe tinnitus, a condition that affects 7M people in the US and Europe, of which 7% attempt suicide every year. It is also developing a family of subdural electrodes intended for monitoring during brain tumor and epilepsy resection surgery.

Engage with Neurosoft Bioelectronics

Press Releases from Neurosoft Bioelectronics :

Neurosoft Bioelectronics Receives Nearly $3 Million in Funding

Neurosoft Bioelectronics Flexible Electrode

Apr 5, 2022 8:00 AM EDT

GENEVA, Switzerland, and NEW YORK, N.Y., April 5, 2022 (SEND2PRESS NEWSWIRE) — Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant.